• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med Microbiol Immunol . Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of e

tetano

Editor, Senior Moderator
Med Microbiol Immunol


. 2022 Jan 21.
doi: 10.1007/s00430-022-00728-7. Online ahead of print.
Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants


Christopher Dächert[SUP] #[/SUP][SUP] 1 [/SUP], Maximilian Muenchhoff[SUP] #[/SUP][SUP] 1 2 [/SUP], Alexander Graf[SUP] #[/SUP][SUP] 1 3 [/SUP], Hanna Autenrieth[SUP] 1 [/SUP], Sabine Bender[SUP] 1 [/SUP], Helga Mairhofer[SUP] 1 [/SUP], Paul R Wratil[SUP] 1 [/SUP], Susanne Thieme[SUP] 3 [/SUP], Stefan Krebs[SUP] 3 [/SUP], Natascha Grzimek-Koschewa[SUP] 1 2 [/SUP], Helmut Blum[SUP] 3 [/SUP], Oliver T Keppler[SUP] 4 [/SUP]



Affiliations

Abstract

On November 26, 2021, the World Health Organization classified B.1.1.529 as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VoC), named omicron. Spike-gene dropouts in conventional SARS-CoV-2 PCR systems have been reported over the last weeks as indirect diagnostic evidence for the identification of omicron. Here, we report the combination of PCRs specific for heavily mutated sites in the spike gene and nanopore-based full-length genome sequencing for the rapid and sensitive identification of the first four COVID-19 patients diagnosed in Germany to be infected with omicron on November 28, 2021. This study will assist the unambiguous laboratory-based diagnosis and global surveillance for this highly contagious VoC with an unprecedented degree of humoral immune escape. Moreover, we propose that specialized diagnostic laboratories should continuously update their assays for variant-specific PCRs in the spike gene of SARS-CoV-2 to readily detect and diagnose emerging variants of interest and VoCs. The combination with established nanopore sequencing procedures allows both the rapid confirmation by whole genome sequencing as well as the sensitive identification of newly emerging variants of this pandemic β-coronavirus in years to come.

Keywords: Melting curve analysis; Nanopore; Omicron; SARS-CoV-2; VOC; VOC-PCR.
 
Back
Top Bottom